Opinion

Allowing Off-Label Data Would Do More to Protect Public Health

Allowing Off-Label Data Would Do More to Protect Public Health

We should make off-label research publicly available in a non-promotional format to both healthcare professionals and patients.

4 Ways for Marketers To Differentiate Their Brands In The Rare-Disease Space

4 Ways for Marketers To Differentiate Their Brands In The Rare-Disease Space

Data analytics, relationship building, and improved patient support are the keys to differentiating your rare-disease drug brands, according to these four marketers.

How Can Marketers Best Unleash the Potential of Virtual Reality?

How Can Marketers Best Unleash the Potential of Virtual Reality?

Does virtual reality represent a new way for marketers to create immersive experiences — or is this just the industry's latest shiny object?

How Should Pharma Deploy Messaging in EHR Systems?

How Should Pharma Deploy Messaging in EHR Systems?

Pharma must be thoughtful in its approach and demonstrate value to be part of the EHR conversation.

What Can We Do About Patient Non-Adherence?

What Can We Do About Patient Non-Adherence?

It's been called "America's other drug problem."

Pharma Marketing as First Mover? Cannes Offers a Glimpse

Pharma Marketing as First Mover? Cannes Offers a Glimpse

By

Pharma marketing has long been deemed slow to adapt. Last weekend's Lions Health festival offered a glimpse of healthcare as a first mover.

Hey Pharma—Chin Up, Fella!

Hey Pharma—Chin Up, Fella!

By

The traditional line of attack is genuine and requires little in the way of spin—yet still, every time a Turing rears its head, it gets blown back in small and indigestible pieces.

Late-Phase Diabetes Research: Time To Get Onboard

Late-Phase Diabetes Research: Time To Get Onboard

If more physicians begin participating in late-phase research efforts—and work to educate patients about these opportunities—we can expect new innovations in treatment solutions to come more quickly to market.

Exploring the Opportunity For Halal In Healthcare

Exploring the Opportunity For Halal In Healthcare

There is an immediate need for greater education regarding halal and vaccines for Muslim consumers worldwide.

Is It Possible For Pharma To Be Truly Patient-centric?

Is It Possible For Pharma To Be Truly Patient-centric?

Although the industry wants to help patients get healthy - and wants to be a critical part in that process - there's a delicate balance to strike between selling product and achieving healthier outcomes.

A Patient Journey Isn't the Solution to Pharma Marketing—It's the Beginning

A Patient Journey Isn't the Solution to Pharma Marketing—It's the Beginning

We need to view the patient journey as a starting place for much deeper analysis.

Pharmanormal activities

Pharmanormal activities

By

When Monique Levy, one of the most-level-headed analysts in the pharma industry, calls attention to a mysterious phenomenon, you listen.

Marketing at 24 Frames per Second

Marketing at 24 Frames per Second

Why healthcare brands need to start speaking in video, and how they can do it

Maybe You Shouldn't Hire a VP of Digital Strategy

Maybe You Shouldn't Hire a VP of Digital Strategy

Agencies struggle to find VPs of digital strategy (or multichannel strategy or engagement strategy) because they don't really need one.

Apple's ResearchKit: Five Guidelines for Pharma

Apple's ResearchKit: Five Guidelines for Pharma

"In this fast-moving environment, we believe these five guidelines will help guide your clinical trial team in taking full advantage of this exciting new platform."

5 Steps to Successful Key Account Management

5 Steps to Successful Key Account Management

The healthcare ecosystem is changing rapidly to succeed requires the adoption of key account management (KAM), a systematic, robust alternative to the traditional buyer/seller model.

Pharma Marketers: Adopt Principles of Sharing Economy to Catalyze New Growth

Pharma Marketers: Adopt Principles of Sharing Economy to Catalyze New Growth

How the adoption of principles from recent, successful start ups can be applied to pharma marketing.

From Misfits to FitBits: CES 2015, The CLINICAL Electronics Show

From Misfits to FitBits: CES 2015, The CLINICAL Electronics Show

Key trends from the latest Consumer Electronics Show through the eyes of NostaLab's John Nosta

Playing to Win in the Global Biosimilars Environment

Playing to Win in the Global Biosimilars Environment

By

"Although the United States represents almost half of the biologics market in terms of revenue and volume, biosimilars growth will be fueled by focusing on the emerging markets, by addressing non-consumption and patient inability to pay for high-priced biologics."

Five Big Shifts in Policy and Technology That Marketers Should Worry about in 2015

Five Big Shifts in Policy and Technology That Marketers Should Worry about in 2015

By

"The trouble is that the market is changing much faster than most marketers realize."

Hey Pharma, Here's Why Your Customer Service Shouldn't Suck

Hey Pharma, Here's Why Your Customer Service Shouldn't Suck

By

"Customer service is more than just a nice-to-have. In this competitive marketplace, it can mean the difference between your brand or someone else's."

The Simple Solution to America's Complex Health Literacy Problem

The Simple Solution to America's Complex Health Literacy Problem

By

"We are living in an era of great medical technological innovations. However, this is shifting healthcare back home and expecting patients to understand excessive medical information and follow complex instructions."

OPINION

Email Newsletters